# ImmunityBio, Inc.: Form 8-K, filed Mar 3, 2025

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2025-03-03
- Accepted by EDGAR: Mar 3, 2025, 07:42 ET
- Period: 2025-03-03
- Accession: 0001326110-25-000031
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000132611025000031/ibrx-20250303.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000132611025000031/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000132611025000031/ibrx-20250303.htm

Filed Mar 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001326110-25-000031. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.